| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/24/2004 | US6696496 Venlafaxine maleate |
| 02/24/2004 | US6696495 Treatment of disorders secondary to organic impairments |
| 02/24/2004 | US6696493 Treating chronic uremic patients undergoing periodic dialysis |
| 02/24/2004 | US6696492 Use of L carnitine and its alkanoyl dervatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy |
| 02/24/2004 | US6696491 Cetyl myristate optionally with cetyl palmitate |
| 02/24/2004 | US6696488 Administering protease inhibitor |
| 02/24/2004 | US6696486 Medical use for atypical β-adrenoceptor agonists |
| 02/24/2004 | US6696485 Cocoa extracts; antitumor, anticancer activity; oxidation resistance; dna topoisomerase ii enzyme inhibition |
| 02/24/2004 | US6696484 Method and compositions for regulation of 5-alpha reductase activity |
| 02/24/2004 | US6696483 Administering golgi apparatus disturbing agents such as brefeldin a, nocodazole, ilimaquinone, bafilamycin, okadaic acid, retinoic acid, and mixtures |
| 02/24/2004 | US6696482 Formulations for hydrophobic pharmaceutical agents |
| 02/24/2004 | US6696481 Immediate-release tablets; treatment of arterial hypertension and heart failure |
| 02/24/2004 | US6696480 Antilipemic, anticholesterol agent |
| 02/24/2004 | US6696479 Crystalline forms |
| 02/24/2004 | US6696478 Compound targeted to protein kinase c enzyme |
| 02/24/2004 | US6696476 Pyranoindazoles and their use for the treatment of glaucoma |
| 02/24/2004 | US6696474 Such as 8-(5-methyl-2-phenyl-oxazol-4-yl)-2-pyrrol-1-yl-oct-4-ynoic acid; noninsulin dependent diabetes mellitus |
| 02/24/2004 | US6696471 Aminopyrrole compounds |
| 02/24/2004 | US6696470 Pyridylthiophene compounds |
| 02/24/2004 | US6696469 For treatment of diseases or pathological conditions in which endothelial dysfunction is known; atherosclerosis, dyslipidaemia, diabetes |
| 02/24/2004 | US6696468 (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| 02/24/2004 | US6696467 Quinoline derivatives |
| 02/24/2004 | US6696466 Montelukast; leukotriene antagonist |
| 02/24/2004 | US6696464 Triazolo-pyridines anti-inflammatory compounds |
| 02/24/2004 | US6696461 Tricyclic imidazopyridines |
| 02/24/2004 | US6696460 Prevention and treatment of gastrointestinal diseases |
| 02/24/2004 | US6696458 Having x-ray powder diffraction pattern with lines at degrees 2 theta values 6.7, 12.5, 14.0 and 23.9 for cu k alpha radiation of wavelength 1.5406 angstrom |
| 02/24/2004 | US6696457 Morphinoid compounds |
| 02/24/2004 | US6696454 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation |
| 02/24/2004 | US6696453 Use of NF-κB inhibitors to treat dry eye disorders |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696451 Dihydropyrimidines |
| 02/24/2004 | US6696449 Control degradation of conencting tissue; cardiovascular disorders |
| 02/24/2004 | US6696447 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 02/24/2004 | US6696446 Benzoylpyridazines, their preparation and use |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/24/2004 | US6696444 Neurotransmitter antagonists comprising compounds such as 4,2'-difluoro-5'-(3-(1-fluoro-1-methylethyl)imidazo(1,2-b)(1,2 ,4) triazin-7-yl)biphenyl-2-carbonitrile, administered for the prophylaxis of headaches or as anticonvulsants |
| 02/24/2004 | US6696443 Piperidine/piperazine-type inhibitors of p38 kinase |
| 02/24/2004 | US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 02/24/2004 | US6696441 Inhibition of p53-induced stress response |
| 02/24/2004 | US6696440 Administering mitogen activated protein kinase(mek) inhibitors comprising secondary carbocyclic amines, as antiasthmatic agents |
| 02/24/2004 | US6696437 Polymerase inhibitors comprising heterocyclic amides such as 2-pyridin-2-ylbenzimidazole-4-carboxamide, used for prophylaxis of neurodegenerative disorders, damage to hearts or brains, and as anticarcinogenic agents |
| 02/24/2004 | US6696434 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 02/24/2004 | US6696433 Use of sex steroids function modulators to treat wounds and fibrotic disorders |
| 02/24/2004 | US6696432 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men |
| 02/24/2004 | US6696429 Especially due to osteoarthrosis, osteochondrosis, navicular disease or enthesopathy of the bony insertions of the tendons, of the ligaments, or of the aponeurosis, particularly in horses |
| 02/24/2004 | US6696428 Use of dopamine receptor antagonists in palliative tumor therapy |
| 02/24/2004 | US6696427 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 02/24/2004 | US6696426 Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems |
| 02/24/2004 | US6696422 Parenterally administering product r, a peptide-nucleic acid preparation, in combination with one or more antiviral agents useful for treating aids or hiv infections including hiv protease inhibitors and nucleosides |
| 02/24/2004 | US6696419 Applying calcium fructoborate or calcium threonine borate, to skins for therapy of inflammation of joints or injuries; transdermal drug delivery |
| 02/24/2004 | US6696407 Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF |
| 02/24/2004 | US6696396 Therapeutic soap |
| 02/24/2004 | US6696303 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 02/24/2004 | US6696273 FEBP1 Protein: vector, host cells and method for making FEBP1 protein |
| 02/24/2004 | US6696263 PCNA associated cell cycle proteins, compositions and methods of use |
| 02/24/2004 | US6696091 Pharmaceutical composition of topiramate |
| 02/24/2004 | US6696090 Micronized medical powder electrostatically charged by corona, induction, or triboelectricity; lung airway or oral inhalation administration of antiasthmatic agent |
| 02/24/2004 | US6696089 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 02/24/2004 | US6696088 Useful for decreasing the potential for abuse of the opioid agonist contained therein; for use in therapy of pain |
| 02/24/2004 | US6696084 Spray drying process and compositions of fenofibrate |
| 02/24/2004 | US6696083 Administering vitamin b1, thiamine, niacinamide, folic acid, riboflavin, pantothenic acid, vitamin b, pyridoxine, and/or vitamin b12 to human during sleep; oxidation resistance |
| 02/24/2004 | US6696080 Vortexing lipid film with water; homogenizing suspension; repeatedly freeze-thawing in liquid nitrogen; encapsulation; giant multivesicular liposomes |
| 02/24/2004 | US6696079 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes |
| 02/24/2004 | US6696078 Applying patch to skin comprising mixture of penetration enhancer, macrolide antibiotic, and tetracycline antibiotic as analgesic for snake and insect bites |
| 02/24/2004 | US6696076 Administering imidazoquinoline amine or imidazopyridine amine as interleukin and cytokine inhibitor |
| 02/24/2004 | US6696072 Mixture of phentolamine mesylate, papaverine hydrochloride, and alprostadil in buffer containing l-arginine and glycine injected into penis |
| 02/24/2004 | US6696066 Opioid agonist/antagonist combinations |
| 02/24/2004 | US6696064 Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy |
| 02/24/2004 | US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 02/24/2004 | US6696059 Administering to patient a therapeutically effective amount of both an n-alkyl derivative of deoxynojirimycin and a glucocerebrosidase enzyme to alleviate or inhibit glycolipid storage disease; gaucher's disease |
| 02/24/2004 | US6696055 Disinfectant substance comprising an iodine impregnated resin for use in sterilizing a fluid such as water or air |
| 02/24/2004 | US6696042 Inhalation aerosol comprising tiotropium salt and propellant gas; respiratory system disorders |
| 02/24/2004 | US6696039 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 02/24/2004 | US6695969 Displacement chromatography and involves using a displacer for displacing the hmg-coa reductase inhibitor |
| 02/24/2004 | US6695842 Interspinous process distraction system and method with positionable wing and method |
| 02/24/2004 | CA2438001A1 Use of the disorazoles and their derivatives for the treatment of benign and malignant oncoses |
| 02/24/2004 | CA2315067C Aqueous insecticidal pour-on formulation |
| 02/24/2004 | CA2309796C Carbonate derivatives of retinol, process for their preparation and uses |
| 02/24/2004 | CA2305750C Stable solution of zinc and bicarbonate ions |
| 02/24/2004 | CA2293461C Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 02/24/2004 | CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 02/24/2004 | CA2199399C .beta.,.beta.'-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from .beta.,.beta.'-unsubstituted tetrapyrrolic macrocyles |
| 02/24/2004 | CA2150944C New taxoids; process for preparing the same and pharmaceutical compositions containing them |
| 02/24/2004 | CA2125401C Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them |
| 02/24/2004 | CA2114542C Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists |
| 02/24/2004 | CA2013519C Sulfonyl derivatives of thieno-triazolo-diazepines, a preparation process of the same and therapeutic compositions containing them |
| 02/24/2004 | CA2013518C Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them |
| 02/23/2004 | CA2399630A1 Scyphostatin analogues as smase inhibitors |
| 02/23/2004 | CA2399532A1 Controlled release formulation of divalproex sodium |
| 02/23/2004 | CA2399528A1 Controlled release formulation of divalproex sodium |
| 02/19/2004 | WO2004015140A1 Methods for the treatment of dementia based on apo e genotype |
| 02/19/2004 | WO2004015131A2 Hepatitis c virus assays |
| 02/19/2004 | WO2004015130A2 Modulators of rabggt and methods of use thereof |
| 02/19/2004 | WO2004015122A1 Method for reproducing pleuromutilins |
| 02/19/2004 | WO2004015107A2 Further novel forms of interfering rna molecules |
| 02/19/2004 | WO2004015096A2 Leech extracts for stents |
| 02/19/2004 | WO2004015089A2 Polyionic organic acid formulations |
| 02/19/2004 | WO2004015062A2 Methods and compositions relating to gene silencing |
| 02/19/2004 | WO2004014958A1 Polysaccharide of echinacea angustifolia |